These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23873765)

  • 41. Chlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein.
    Bulir DC; Waltho DA; Stone CB; Liang S; Chiang CK; Mwawasi KA; Nelson JC; Zhang SW; Mihalco SP; Scinocca ZC; Mahony JB
    BMC Microbiol; 2015 Aug; 15():163. PubMed ID: 26272448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure and interactions of the cytoplasmic domain of the Yersinia type III secretion protein YscD.
    Gamez A; Mukerjea R; Alayyoubi M; Ghassemian M; Ghosh P
    J Bacteriol; 2012 Nov; 194(21):5949-58. PubMed ID: 22942247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secretion of the chlamydial virulence factor CPAF requires the Sec-dependent pathway.
    Chen D; Lei L; Lu C; Flores R; DeLisa MP; Roberts TC; Romesberg FE; Zhong G
    Microbiology (Reading); 2010 Oct; 156(Pt 10):3031-3040. PubMed ID: 20522495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic and functional analysis of the suite of Ysp proteins exported by the Ysa type III secretion system of Yersinia enterocolitica Biovar 1B.
    Matsumoto H; Young GM
    Mol Microbiol; 2006 Jan; 59(2):689-706. PubMed ID: 16390460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Type III secretion translocon assemblies that attenuate Yersinia virulence.
    Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
    Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of a
    Yanatori I; Miura K; Chen YS; Valdivia RH; Kishi F
    J Bacteriol; 2021 Jun; 203(11):. PubMed ID: 33685970
    [No Abstract]   [Full Text] [Related]  

  • 49. Multipart Chaperone-Effector Recognition in the Type III Secretion System of Chlamydia trachomatis.
    Shen L; Macnaughtan MA; Frohlich KM; Cong Y; Goodwin OY; Chou CW; LeCour L; Krup K; Luo M; Worthylake DK
    J Biol Chem; 2015 Nov; 290(47):28141-28155. PubMed ID: 26438824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical Role for the Extended N Terminus of Chlamydial MreB in Directing Its Membrane Association and Potential Interaction with Divisome Proteins.
    Lee J; Cox JV; Ouellette SP
    J Bacteriol; 2020 Apr; 202(9):. PubMed ID: 32041796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CT295 Is
    Triboulet S; N'Gadjaga MD; Niragire B; Köstlbacher S; Horn M; Aimanianda V; Subtil A
    Front Cell Infect Microbiol; 2022; 12():866729. PubMed ID: 35795184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the N-terminal secretor domain on YopD translocator function in Yersinia pseudotuberculosis type III secretion.
    Amer AA; Åhlund MK; Bröms JE; Forsberg Å; Francis MS
    J Bacteriol; 2011 Dec; 193(23):6683-700. PubMed ID: 21965570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Translocation of surface-localized effectors in type III secretion.
    Akopyan K; Edgren T; Wang-Edgren H; Rosqvist R; Fahlgren A; Wolf-Watz H; Fallman M
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1639-44. PubMed ID: 21220342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CteG is a Chlamydia trachomatis effector protein that associates with the Golgi complex of infected host cells.
    Pais SV; Key CE; Borges V; Pereira IS; Gomes JP; Fisher DJ; Mota LJ
    Sci Rep; 2019 Apr; 9(1):6133. PubMed ID: 30992493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The YscU/FlhB homologue HrcU from Xanthomonas controls type III secretion and translocation of early and late substrates.
    Hausner J; Büttner D
    Microbiology (Reading); 2014 Mar; 160(Pt 3):576-588. PubMed ID: 24425767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Type III Secretion Chaperone HpaB Controls the Translocation of Effector and Noneffector Proteins From Xanthomonas campestris pv. vesicatoria.
    Scheibner F; Hartmann N; Hausner J; Lorenz C; Hoffmeister AK; Büttner D
    Mol Plant Microbe Interact; 2018 Jan; 31(1):61-74. PubMed ID: 28771395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A solvent-exposed patch in chaperone-bound YopE is required for translocation by the type III secretion system.
    Rodgers L; Mukerjea R; Birtalan S; Friedberg D; Ghosh P
    J Bacteriol; 2010 Jun; 192(12):3114-22. PubMed ID: 20382763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eukaryotic Cell Permeabilisation to Identify New Putative Chlamydial Type III Secretion System Effectors Secreted within Host Cell Cytoplasm.
    Kebbi-Beghdadi C; Pilloux L; Martin V; Greub G
    Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32138376
    [No Abstract]   [Full Text] [Related]  

  • 59. Secretion of type III effectors into host cells in real time.
    Enninga J; Mounier J; Sansonetti P; Tran Van Nhieu G
    Nat Methods; 2005 Dec; 2(12):959-65. PubMed ID: 16299482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-accuracy prediction of bacterial type III secreted effectors based on position-specific amino acid composition profiles.
    Wang Y; Zhang Q; Sun MA; Guo D
    Bioinformatics; 2011 Mar; 27(6):777-84. PubMed ID: 21233168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.